Health-Related Quality of Life as Measured by the 36-Item Short Form Survey Among Adults With Acute Bacterial Skin and Skin Structure Infections who Received Either Omadacycline or Linezolid in a Phase 3 Double-Blind, Double-Dummy Clinical Trial-Reference-Cited by-同舟云学术

Health-Related Quality of Life as Measured by the 36-Item Short Form Survey Among Adults With Acute Bacterial Skin and Skin Structure Infections who Received Either Omadacycline or Linezolid in a Phase 3 Double-Blind, Double-Dummy Clinical Trial

Published:2021-09-08 Issue:10 Volume:8 Page:
ISSN:2328-8957
Container-title:Open Forum Infectious Diseases
language:en
Short-container-title:

Author:

Chitra Surya¹,Hinahara Jordan²,Goss Thomas F²,Gunter Kyle¹,LaPensee Kenneth¹

Affiliation:

1. Paratek Pharmaceuticals, Inc., King of Prussia, Pennsylvania, USA

2. Boston Healthcare Associates, Inc., Boston, Massachusetts, USA

Abstract

Abstract This analysis of data from a Phase 3 study of adults with acute bacterial skin and skin structure infections showed that successful oral treatment with omadacycline (n = 368) or linezolid (n = 367) was associated with improvement in health-related quality of life.

Funder

Paratek Pharmaceuticals, Inc

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Oncology

Link

http://academic.oup.com/ofid/advance-article-pdf/doi/10.1093/ofid/ofab459/40327262/ofab459.pdf

Reference22 articles.

1. Structure-activity relationship of the aminomethylcyclines and the discovery of omadacycline;Honeyman;Antimicrob Agents Chemother,2015

2. Omadacycline: development of a novel aminomethylcycline antibiotic for treating drug-resistant bacterial infections;Villano;Future Microbiol,2016

3. Discovery, pharmacology, and clinical profile of omadacycline, a novel aminomethylcycline antibiotic;Tanaka;Bioorg Med Chem,2016

4. In vitro and in vivo antibacterial activities of omadacycline, a novel aminomethylcycline;Macone;Antimicrob Agents Chemother,2014